statistiche ricercatore

Continente	#
NA - Nord America	1.407
EU - Europa	860
AS - Asia	609
Continente sconosciuto - Info sul continente non disponibili	104
SA - Sud America	85
AF - Africa	40
OC - Oceania	4
Totale	3.109

Nazione	#
US - Stati Uniti d'America	1.370
IT - Italia	227
SG - Singapore	204
DE - Germania	153
CN - Cina	143
PL - Polonia	101
SE - Svezia	84
FI - Finlandia	75
VN - Vietnam	65
BR - Brasile	57
HK - Hong Kong	51
GB - Regno Unito	45
FR - Francia	36
BD - Bangladesh	34
NL - Olanda	28
RU - Federazione Russa	24
BE - Belgio	21
IN - India	17
MX - Messico	17
KR - Corea	16
JP - Giappone	15
UA - Ucraina	15
TR - Turchia	14
CA - Canada	12
IE - Irlanda	12
BG - Bulgaria	11
AR - Argentina	9
ES - Italia	9
SA - Arabia Saudita	9
TN - Tunisia	8
MA - Marocco	7
CL - Cile	5
CO - Colombia	5
EG - Egitto	5
PH - Filippine	5
SN - Senegal	5
AT - Austria	4
DZ - Algeria	4
ID - Indonesia	4
IQ - Iraq	4
UZ - Uzbekistan	4
ZA - Sudafrica	4
AU - Australia	3
AZ - Azerbaigian	3
IL - Israele	3
TW - Taiwan	3
AE - Emirati Arabi Uniti	2
CI - Costa d'Avorio	2
CZ - Repubblica Ceca	2
EC - Ecuador	2
GR - Grecia	2
JM - Giamaica	2
JO - Giordania	2
KG - Kirghizistan	2
PY - Paraguay	2
SK - Slovacchia (Repubblica Slovacca)	2
TH - Thailandia	2
VE - Venezuela	2
AO - Angola	1
BB - Barbados	1
BH - Bahrain	1
BO - Bolivia	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
GH - Ghana	1
HN - Honduras	1
IR - Iran	1
IS - Islanda	1
KE - Kenya	1
KZ - Kazakistan	1
LT - Lituania	1
LU - Lussemburgo	1
LV - Lettonia	1
MD - Moldavia	1
MK - Macedonia	1
MM - Myanmar	1
MQ - Martinica	1
MY - Malesia	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PK - Pakistan	1
PT - Portogallo	1
RO - Romania	1
RS - Serbia	1
RW - Ruanda	1
UY - Uruguay	1
Totale	3.005

Nome	#
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants	517
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients	304
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study	302
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease	272
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives	271
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease.	267
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay	259
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease	259
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient	255
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease	240
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome	163
Totale	3.109

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	163	0	0	4	13	10	15	7	6	16	18	21	53
2022/2023	255	23	48	14	41	32	38	1	25	19	4	10	0
2023/2024	156	4	7	8	9	18	18	26	26	4	5	20	11
2024/2025	577	13	23	30	38	43	71	63	62	91	64	43	36
2025/2026	858	103	14	43	63	69	73	105	32	120	129	73	34
2026/2027	110	16	67	27	0	0	0	0	0	0	0	0	0
Totale													3.109

ArTS Archivio della ricerca di Trieste